BeStock  
Stocks › Biotechnology › PTCT

PTC Therapeutics PTCT

US equityMarket cap rank #2094Biotechnology
$56.42 −$1.91 (-3.27%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $56.99 +1.01%
Open$58.78
Prev close$58.33
Day range$56.18 – $58.96
Volume952.6K
Market cap$4.71B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts12
Average target$100.00+77.2% vs. price
  • Buy 83%
  • Hold 17%
Low $62.00Now $56.42Avg $100.00High $137.00

Recent rating changes

The last 20 actions on file set price targets from $62.00 to $137.00, averaging $98.24.

DateFirmRatingTarget
5 Nov 2026 J.P. Morgan BUY $92.00
2 Nov 2026 Citi BUY $109.00
2 Nov 2026 Barclays BUY $122.00
2 Nov 2026 J.P. Morgan BUY $92.00
30 Oct 2026 TD Cowen BUY $95.00
30 Oct 2026 Wells Fargo BUY $112.00
30 Oct 2026 UBS BUY $90.00
30 Oct 2026 BofA Securities BUY –
29 Oct 2026 Cantor Fitzgerald BUY $137.00
29 Oct 2026 RBC Capital HOLD $77.00
27 Oct 2026 RBC Capital HOLD $75.00
20 Oct 2026 Raymond James BUY $106.00
19 Oct 2026 Wells Fargo BUY $109.00
16 Oct 2026 UBS BUY $90.00
16 Oct 2026 Truist Financial HOLD $62.00
15 Oct 2026 UBS BUY $90.00
14 Oct 2026 UBS BUY $90.00
14 Oct 2026 J.P. Morgan BUY –
9 Oct 2026 BofA Securities BUY –
7 Oct 2026 Barclays BUY $122.00

Discussion

No comments yet — be the first to weigh in on PTCT.

Sign in to join the discussion.

Scroll to Top